EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ORF2 of hepatitis E virus: genetic and antigenic variation across genotypes and implications for immunity, diagnostics and vaccine development

Sherif A El-Kafrawy, Sigit S Putra, Ayman T Abbas, Umama A Abdel-Dayem, Thamir A Alandijany, Hisham N Altayb, Esam I Azhar

Journal of General Virology · 2026

DOI: 10.1099/jgv.0.002342 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of General Virology, 2026. Verfasst von Sherif A El-Kafrawy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Hepatitis E virus, Antigenic Variation, Hepatitis E, Viral Proteins. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdulaziz University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis E virus (HEV) causes over 19 million infections annually, yet the molecular determinants governing its diverse clinical phenotypes and cross-genotype immunity remain incompletely synthesized. The ORF2 capsid protein is the sole structural component of the virion, the primary neutralizing antibody target and the basis for all commercial diagnostics and the only licensed vaccine (Hecolin®). While current literature often treats HEV as a monolithic antigenic entity, ORF2 sequences diverge by 15–25% across the eight recognized genotypes (GT1–GT8), with critical substitutions concentrated in the protruding (P) domain neutralizing epitopes. This comprehensive review integrates recent structural, virological and clinical data to evaluate the multidimensional impact of ORF2 variability. We highlight how the differential expression of three ORF2 isoforms (infectious ORF2i, secreted decoy ORF2g and cleaved ORF2c) complicates immune recognition. Furthermore, we critically analyse the functional consequences of P domain divergence, which results in 2–4-fold reduced cross-genotype neutralization by GT1-derived vaccines against the globally emerging GT3 and drives false-negative rates of 12–30% in commercial serological assays. Finally, we map ORF2 genetic signatures to distinct clinical phenotypes, including GT1-associated pregnancy mortality and GT3-driven chronicity in transplant recipients. By synthesizing these fragmented domains, this review identifies critical knowledge gaps, particularly concerning the zoonotic emergence of GT7/GT8 and provides a prioritized research roadmap for the development of true pan-genotype vaccines and universal diagnostic algorithms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis E virusAntigenic VariationHepatitis EViral ProteinsViral Hepatitis VaccinesHumansGenotypeVaccine DevelopmentGenetic VariationAnimalsAntigens, ViralAntibodies, Neutralizing

Stichwörter der Autor:innen

ORF2 capsid proteinORF2 isoformsantigenic diversitycross-genotype immunitygenetic variationhepatitis E viruspan-genotype diagnosticsvaccine development

Substanzen

Viral ProteinsORF2 protein, Hepatitis E virusViral Hepatitis VaccinesAntigens, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Special Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Animal Facility Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
  • Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.

Förderung

  • King Abdulaziz University

Zitieren

APA

El-Kafrawy, S. A., Putra, S. S., Abbas, A. T., Abdel-Dayem, U. A., Alandijany, T. A., Altayb, H. N., & Azhar, E. I. (2026). ORF2 of hepatitis E virus: genetic and antigenic variation across genotypes and implications for immunity, diagnostics and vaccine development. Journal of General Virology. https://doi.org/10.1099/jgv.0.002342

Vancouver

El-Kafrawy SA, Putra SS, Abbas AT, Abdel-Dayem UA, Alandijany TA, Altayb HN, et al. ORF2 of hepatitis E virus: genetic and antigenic variation across genotypes and implications for immunity, diagnostics and vaccine development. Journal of General Virology. 2026. doi:10.1099/jgv.0.002342

BibTeX
@article{ElKafrawy2026,
  author = {El-Kafrawy, Sherif A and Putra, Sigit S and Abbas, Ayman T and Abdel-Dayem, Umama A and Alandijany, Thamir A and Altayb, Hisham N and Azhar, Esam I},
  title = {ORF2 of hepatitis E virus: genetic and antigenic variation across genotypes and implications for immunity, diagnostics and vaccine development},
  journal = {Journal of General Virology},
  year = {2026},
  doi = {10.1099/jgv.0.002342}
}
Kostenlos starten →